Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) (C-Term) Peptide

BCAR1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN8095672
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) (C-Term) Peptide (ABIN8095672)

Antigène

BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))

Origine

Humain

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Fonction

    BCAR1 Peptide - C-terminal region

    Séquence

    YVHLQGKEEF EKTQKELLEK GSITRQGKSQ LELQQLKQFE RLEQEVSRPI
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-BCAR1 Antibody (ARP63355_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))

    Sujet

    Background Information: BCAR1, or CAS, is an Src family kinase substrate involved in various cellular events, including migration, survival, transformation, and invasion.

    Alternative Symbols: CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas

    Poids moléculaire

    72kDa

    ID gène

    9564

    NCBI Accession

    NP_001164192

    UniProt

    B3KWE2
Vous êtes ici:
Chat with us!